Summit Therapeutics (SUMM)

 

Latest News

Summit Therapeutics plc : Notice of AGM

Notification of a company’s annual general meeting

Summit Therapeutics plc : Holding(s) in Company

Notification of major interests in shares

Summit Therapeutics plc : Total voting rights

Notification of a change in the total number of voting rights

Director Deals - Summit Therapeutics PLC (SUMM)

Prof Stephen Davies, Non Executive Director, exercised 17,500 shares in the company on the 23rd April 2018 at a price of 1.0...

All News

DateHeadlineSource
03-05-18Summit Therapeutics plc : Notice of AGMRNS
02-05-18Summit Therapeutics plc : Holding(s) in CompanyRNS
01-05-18Summit Therapeutics plc : Total voting rightsRNS
23-04-18Director Deals - Summit Therapeutics PLC (SUMM)StockMarketWire
23-04-18Director Deals - Summit Therapeutics PLC (SUMM)StockMarketWire
23-04-18Summit Therapeutics plc : Director/PDMR ShareholdingRNS
23-04-18Summit Therapeutics advances gonorrhoea treatment plansStockMarketWire
23-04-18Summit Highlights Discovery of New Mechanism Antibiotics for the Treatment of Gonorrhoea at ECCMID 2018RNS
23-04-18Summit Therapeutics plc : Grant of Share Options and RSUsRNS
20-04-18Summit Presents New 24-Week Analyses from PhaseOut DMD at the 2018 AAN ConferenceRNS
19-04-18Summit Completes Dosing of Ezutromid in PhaseOut DMD Clinical TrialRNS
13-04-18Summit Therapeutics Files US Annual Report on Form 20FRNS
11-04-18Summit Therapeutics Reports Financial Results for the Fiscal Year Ended 31 January 2018RNS
11-04-18Summit Therapeutics plc : Total voting rightsRNS
10-04-18Summit Therapeutics plc : Director/PDMR ShareholdingRNS
09-04-18Summit Therapeutics plc : Notice of ResultsRNS
06-04-18Summit Therapeutics plc : Block listing Interim ReviewRNS
05-04-18Summit Therapeutics to Present at the H.C. Wainwright Global Life Sciences ConferenceRNS
05-04-18Summit Therapeutics plc : Holding(s) in CompanyRNS
28-03-18Summit Therapeutics Selected for Emerging Science Presentation at the 2018 AAN Annual MeetingRNS
27-03-18Summit Therapeutics Announces the Results of Placing and Issue of EquityRNS
27-03-18Summit Therapeutics launches £15.0m placement to fund treatment trialsStockMarketWire
27-03-18Summit Therapeutics Announces a Proposed Placing to Raise up to £15 MillionRNS
14-03-18Summit Highlights Scientific Rigour of its PhaseOut DMD Clinical Trial at MDA Clinical ConferenceRNS
13-03-18Summit Therapeutics discovers new compounds that kill gonorrhoeaStockMarketWire
13-03-18Summit's Infectious Diseases Technology Platform Yields Novel Antibiotics with Potential in Global Fight Against GonorrhoeaRNS
07-03-18Summit Expands Enrolment in Phase 2 Clinical Trial to Include Planned Additional GroupRNS
26-02-18Summit Therapeutics plc : Research UpdateRNS
23-02-18Summit Therapeutics to Participate in 2018 BTIG Healthcare ConferenceRNS
09-02-18Summit Therapeutics to Participate in Upcoming Investor ConferencesRNS
25-01-18Summit Therapeutics plc : Interim 24-Week Data from PhaseOut DMDRNS
09-01-18Summit Therapeutics to Present at the Biotech ShowcaseRNS
27-12-17Summit in £10m antibiotics R&D dealStockMarketWire
27-12-17Acquisition of Discuva LtdRNS
21-12-17Summit enters licence agreement in Latin AmericaStockMarketWire
21-12-17Summit Enters Licence and Commercialisation Agreement with Eurofarma for Latin American Rights to RidinilazoleRNS
06-12-17Summit Therapeutics plc : 3rd Quarter ResultsRNS
06-12-17Summit, Santhera, Catabasis and Duchenne UK to Host DMD Awareness DayRNS
04-12-17Summit schedules interim results announcementStockMarketWire
04-12-17Summit Therapeutics plc : Notice of Third Quarter ResultsRNS

RSS feeds

  • Editorial news feed for LSE:SUMM Editorial
  • Regulatory news feed for LSE:SUMM Regulatory